Current Cancer Drug Targets

Ruiwen Zhang 
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106
USA

Back

Most Accessed Articles

HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles open access plus

Volume: 17   Issue: 7
Pp: 637-649
Sarah L. Sammons, Donna L. Topping and Kimberly L. Blackwell*
DOI: 10.2174/1568009617666170330120452

Order Reprints Order Eprints

Multiple Myeloma and the Immune Microenvironment

Volume: 17   Issue: 9
Pp: 806-818
Yawara Kawano, Aldo. M. Roccaro, Irene M. Ghobrial* and Jamil Azzi*
DOI: 10.2174/1568009617666170214102301

Order Reprints Order Eprints

Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies

Volume: 16   Issue: 9
Pp: 755-764
Senthamil R. Selvan, John P. Dowling, William K. Kelly and Jianqing Lin
DOI: 10.2174/1568009615666151030102250

Order Reprints Order Eprints

Immunomodulatory Drugs (IMiDs) in Multiple Myeloma

Volume: 17   Issue: 9
Pp: 846-857
Shahzad Raza, Rachael A. Safyan and Suzanne Lentzsch*
DOI: 10.2174/1568009617666170214104426

Order Reprints Order Eprints

Epithelial-to-Mesenchymal Transition: A Mediator of Sorafenib Resistance in Advanced Hepatocellular Carcinoma

Volume: 17   Issue: 8
Pp: 698-706
Nabiel Mir, Aparna Jayachandran, Bijay Dhungel, Ritu Shrestha and Jason C. Steel*
DOI: 10.2174/1568009617666170427104356

Order Reprints Order Eprints

Cancer Stem Cells in Solid and Liquid Tissues of Breast Cancer Patients: Characterization and Therapeutic Perspectives open access plus

Volume: 15   Issue: 3
Pp: 256-269
Rena Chiotaki, Hara Polioudaki and Panayiotis A. Theodoropoulos
DOI: 10.2174/1568009615666150211102503

Order Reprints Order Eprints

Potential Therapeutic Targets in Energy Metabolism Pathways of Breast Cancer

Volume: 17   Issue: 8
Pp: 707-721
Rowshan Ara Islam, Sazzad Hossain and Ezharul Hoque Chowdhury*
DOI: 10.2174/1568009617666170330150458

Order Reprints Order Eprints